‹ back to list

ViroGates A/S

Healthcare Buildings
Medical Devices

What we offer

Our health solution focusses on how the test for the suPAR biomarker can best be applied to help clinicians in their daily work. We offer different test technologies to suit different users and we collaborate with researchers to bring out more knowledge on various clinical aspects where suPAR might be of help.

Products and solutions

suPARnostic® is developed to measure the amount of suPAR protein in human blood. If individual's suPARnostic® level is very high, there is an increased risk of a negative outcome (e.g. mortality). Appropriate treatment should result in a lowered suPARnostic® level. suPARnostic® can improve the way seemingly low risk patients are managed - a low suPAR level helps avoid time and resources spent on further investigations, an elevated suPAR level is an indication that the patient is at higher risk of not surviving and it should be further investigated if this is caused by one or more developing diseases. By measuring an individual's suPARnostic® level, the patients risk of non-survival will be determined allowing the doctor to prioritise selection of treatment and monitoring.Link to product: Read More

Case stories

Link to three case stories:Read More



ViroGates A/S

Blokken 45
3460 Birkerød

Find us here:

Others also viewed
A-Data A/S See profile ›

我们可为您安排您在丹麦的 考察行程 。

快讯 - 最新资讯